Concepedia

Martina Ittensohn

MI

9

Publications

1.5K

Citations

9

H-Index

1988

Active since

Affiliations

Vion Pharmaceuticals (United States)(Current)

Yale University

Alexion Pharma (Switzerland)

Martina Ittensohn is an author at Vion Pharmaceuticals (United States) specializing in medicine, pathogenesis, and immunotherapy.

Top concepts

Publications per year

1988–2009

9

Publications

9

Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

K. Brooks Low, Martina Ittensohn, Trung Bao Le et al. · Nature Biotechnology · 1999 · 465 citations

, , +12

Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of<i>Salmonella typhimurium</i>

Caroline Clairmont, K. C. Lee, Jeremy A. Pike et al. · The Journal of Infectious Diseases · 2000 · 334 citations · Full text

Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

R. Moll, T Achtstätter, E. Becht et al. · PubMed Central · 1988 · 193 citations · Full text

Tumor-Targeted <i>Salmonella</i> Expressing Cytosine Deaminase as an Anticancer Agent

Ivan King, David Bermudes, Stanley L. Lin et al. · Human Gene Therapy · 2002 · 117 citations

Antitumor Effect of VNP20009, an Attenuated <b><i>Salmonella</i></b>, in Murine Tumor Models

Xiaobo Luo, Zeying Li, Stanley L. Lin et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2001 · 114 citations · Full text

, , +15

Rows per page

1–5 of 9